AAA September 2016 – Page 14

Proclara gets $47m and a new identity

US-headquartered biotechnology company Proclara Biosciences closed a $47m series E round yesterday backed by Merieux Developpement, the strategic investment arm of healthcare technology provider Institut Mérieux. The round, which included undisclosed exiting investors, was announced as Proclara changed its name from NeuroPhage Pharmaceuticals. It increased the company’s overall funding to more than $110m. Proclara is… Continue reading Proclara gets $47m and a new identity